US Stock MarketDetailed Quotes
CLOV Clover Health
- 4.330
- +0.130+3.10%
Close Nov 4 16:00 ET
- 4.330
- 0.0000.00%
Post 19:59 ET
2.15BMarket Cap-18041P/E (TTM)
4.390High4.080Low6.45MVolume4.200Open4.200Pre Close27.45MTurnover1.65%Turnover RatioLossP/E (Static)497.47MShares4.71052wk High6.63P/B1.70BFloat Cap0.60652wk Low--Dividend TTM391.84MShs Float28.850Historical High--Div YieldTTM7.38%Amplitude0.606Historical Low4.253Avg Price1Lot Size
Clover Health Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.28%356.26M | 7.74%346.92M | -41.50%2.03B | -43.23%510.25M | -43.74%482.07M | -62.19%320.14M | -63.17%321.99M | 136.19%3.48B | 108.04%898.79M | 100.58%856.82M |
| Operating revenue | 11.30%349.9M | 7.77%341.72M | -42.02%2.01B | -43.90%500.94M | -44.06%477.27M | -62.83%314.38M | -63.68%317.09M | 136.19%3.47B | 107.81%892.86M | 100.14%853.2M |
| Cost of revenue | 1.67%248.35M | -3.50%265.16M | -48.57%1.78B | -49.87%447.99M | -50.11%418.96M | -71.56%244.26M | -68.11%274.79M | 122.67%3.45B | 102.21%893.65M | 92.47%839.8M |
| Gross profit | 42.22%107.91M | 73.21%81.76M | 1,031.88%257.33M | 1,109.99%62.27M | 270.83%63.11M | 727.80%75.88M | 272.94%47.2M | 128.71%22.74M | 152.01%5.15M | 285.75%17.02M |
| Operating expense | 0.24%100.25M | -16.77%104.11M | 11.57%440M | -2.28%109.92M | 13.33%103.26M | 10.33%100.01M | 24.92%125.09M | -29.30%394.38M | -36.41%112.49M | -34.96%91.11M |
| Selling and administrative expenses | -4.06%99.92M | -18.03%103.79M | -8.61%444.73M | -11.60%109.93M | -13.27%102.31M | -11.39%104.15M | -0.13%126.63M | 9.17%486.64M | 9.00%124.35M | -1.04%117.97M |
| -General and administrative expense | -4.06%99.92M | -18.03%103.79M | -8.61%444.73M | -11.60%109.93M | -13.27%102.31M | -11.39%104.15M | -0.13%126.63M | 9.17%486.64M | 9.00%124.35M | -1.04%117.97M |
| Depreciation amortization depletion | -66.97%330K | 13.98%318K | 111.37%2.51M | 180.14%674K | -9.58%557K | 70.48%999K | -66.22%279K | -4.74%1.19M | -199.17%-841K | 413.33%616K |
| -Depreciation and amortization | -66.97%330K | 13.98%318K | 111.37%2.51M | 180.14%674K | -9.58%557K | 70.48%999K | -66.22%279K | -4.74%1.19M | -199.17%-841K | 413.33%616K |
| Other operating expenses | ---- | ---- | 92.25%-7.24M | 93.80%-683K | 101.43%392K | 81.30%-5.14M | 93.41%-1.81M | -184.32%-93.45M | -117.78%-11.02M | -232.34%-27.48M |
| Operating profit | 131.74%7.66M | 71.31%-22.35M | 50.85%-182.67M | 55.61%-47.65M | 45.81%-40.16M | 76.51%-24.13M | 10.96%-77.89M | 41.66%-371.65M | 42.53%-107.34M | 50.36%-74.1M |
| Net non-operating interest income expense | 0 | 99.49%-7K | 0 | 0 | 98.28%-7K | 91.94%-1.36M | 66.26%-139K | 3.05%-413K | ||
| Non-operating interest expense | --0 | ---- | -99.49%7K | --0 | --0 | -98.28%7K | ---- | -91.94%1.36M | -66.26%139K | -3.05%413K |
| Other net income (expense) | 89.68%-490K | 54.62%-820K | -191.76%-30.69M | -198.12%-22.82M | -33.98%-1.31M | -287.12%-4.75M | -114.58%-1.81M | -49.44%33.44M | 23.26M | -100.85%-980K |
| Gain on sale of security | ---17K | ---467K | -147.56%-4.81M | ---- | ---- | ---- | ---- | -84.71%10.12M | ---70K | -100.85%-980K |
| Special income (charges) | 90.04%-473K | 80.46%-353K | -210.93%-25.88M | -177.19%-18.01M | ---1.31M | ---4.75M | ---1.81M | --23.33M | --23.33M | --0 |
| -Less：Restructuring and merger&acquisition | -90.04%473K | -80.46%353K | --9.93M | --2.06M | --1.31M | --4.75M | --1.81M | --0 | --0 | --0 |
| -Less:Impairment of capital assets | ---- | ---- | --15.95M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---23.33M | ---- | ---- |
| Income before tax | 124.82%7.17M | 70.93%-23.17M | 37.17%-213.36M | 16.33%-70.47M | 45.07%-41.47M | 72.32%-28.89M | -5.57%-79.7M | 42.23%-339.57M | 55.01%-84.23M | -118.64%-75.49M |
| Income tax | ||||||||||
| Net income | 125.71%7.41M | 73.60%-19.17M | 37.17%-213.36M | 16.33%-70.47M | 45.07%-41.47M | 72.39%-28.81M | 3.82%-72.61M | 42.23%-339.57M | 55.01%-84.23M | -118.64%-75.49M |
| Net income continuous Operations | 124.82%7.17M | 70.93%-23.17M | 37.17%-213.36M | 16.33%-70.47M | 45.07%-41.47M | 72.32%-28.89M | -5.57%-79.7M | 42.23%-339.57M | 55.01%-84.23M | -118.64%-75.49M |
| Net income discontinuous operations | 217.33%238K | -43.60%4M | ---- | ---- | ---- | --75K | --7.09M | ---- | ---- | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 125.71%7.41M | 73.60%-19.17M | 37.17%-213.36M | 16.33%-70.47M | 45.07%-41.47M | 72.39%-28.81M | 3.82%-72.61M | 42.23%-339.57M | 55.01%-84.23M | -118.64%-75.49M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 125.71%7.41M | 73.60%-19.17M | 37.17%-213.36M | 16.33%-70.47M | 45.07%-41.47M | 72.39%-28.81M | 3.82%-72.61M | 42.23%-339.57M | 55.01%-84.23M | -118.64%-75.49M |
| Basic earnings per share | 116.67%0.01 | 75.00%-0.04 | 38.03%-0.44 | 16.80%-0.1463 | 43.75%-0.09 | 72.73%-0.06 | 0.00%-0.16 | 50.00%-0.71 | 55.77%-0.1759 | -100.00%-0.16 |
| Diluted earnings per share | 116.67%0.01 | 75.00%-0.04 | 38.03%-0.44 | 16.80%-0.1463 | 43.75%-0.09 | 72.73%-0.06 | 0.00%-0.16 | 50.00%-0.71 | 55.77%-0.1759 | -100.00%-0.16 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data